Tuesday, March 18, 2025
Home 2020 August

Monthly Archives: August 2020

Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
video
Video

Video: What to Look for in Public Company Management.

Editor / Curator -
Uncategorized

CoronaVirus Highlights Need for Leap in Mental Health Medication.

Editor / Curator -
Biotech News

American BriVision’s (ABVC) Novel Polygala Plant Extract, for the Treatment of...

Editor / Curator -
video
Stand Down.

Video: The Bankruptcy Breakdown (Bloomberg).

Editor / Curator -
All News

Look What We Found. A Bavarian Cure for the Common Cold...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Editor / Curator -
Stand Down.

Video: 2020 Year of Crisis: Markets Melt Up (Bloomberg).

Editor / Curator -
Biotech Stock Review, Aphex BioCLeanse
Superbug News - CoronaVirus Watch List

Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.

Editor / Curator -
12Page 1 of 2

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.